Tissium raises €30M in equity, €30M in debt

A French startup which uses a novel technology to reconstruct damaged tissue and restore it to its natural state has raised €30m in equity and taken out up to €30m in debt financing, it said today. Tissium has developed materials called ”biomorphic programmable polymers” that act as an adhesive, which bind nerves together inside tissue, circumventing the need for invasive stitches. Its goal is to reduce trauma to the surrounding tissue and improve recovery rates in patients.